Silencing synuclein at the synapse with PLK2

Por Looyenga, Brendan D., Brundin, Patrik
Publicado em 2013

Characterization of Differential Protein Tethering at the Plasma Membrane in Response to Epidermal Growth Factor Signaling

Por Looyenga, Brendan D., MacKeigan, Jeffrey P.
Publicado em 2012

Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway

Por Looyenga, Brendan D., Resau, James, MacKeigan, Jeffrey P.
Publicado em 2013

Correction: Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway

Por Looyenga, Brendan D., Resau, James, MacKeigan, Jeffrey P.
Publicado em 2014

Inhibin-A Antagonizes TGFβ2 Signaling by Down-Regulating Cell Surface Expression of the TGFβ Coreceptor Betaglycan

Por Looyenga, Brendan D., Wiater, Ezra, Vale, Wylie, Hammer, Gary D.
Publicado em 2010

Tailoring Tyrosine Kinase Inhibitors to Fit the Lung Cancer Genome

Por Looyenga, Brendan D, Cherni, Irene, MacKeigan, Jeffrey P, Weiss, Glen J
Publicado em 2011

STAT3 Is Activated by JAK2 Independent of Key Oncogenic Driver Mutations in Non-Small Cell Lung Carcinoma

Por Looyenga, Brendan D., Hutchings, Danielle, Cherni, Irene, Kingsley, Chris, Weiss, Glen J., MacKeigan, Jeffrey P.
Publicado em 2012

Activin Induces x-Zone Apoptosis That Inhibits Luteinizing Hormone-Dependent Adrenocortical Tumor Formation in Inhibin-Deficient Mice

Por Beuschlein, Felix, Looyenga, Brendan D., Bleasdale, Stephanie E., Mutch, Chris, Bavers, David L., Parlow, Albert F., Nilson, John H., Hammer, Gary D.
Publicado em 2003

A mitochondrial RNAi screen defines cellular bioenergetic determinants and identifies an adenylate kinase as a key regulator of ATP levels

Por Lanning, Nathan J., Looyenga, Brendan D., Kauffman, Audra L., Niemi, Natalie M., Sudderth, Jessica, DeBerardinis, Ralph J., MacKeigan, Jeffrey P.
Publicado em 2014

Identification of PTPσ as an autophagic phosphatase

Por Martin, Katie R., Xu, Yong, Looyenga, Brendan D., Davis, Ryan J., Wu, Chia-Lun, Tremblay, Michel L., Xu, H. Eric, MacKeigan, Jeffrey P.
Publicado em 2011

Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas

Por Looyenga, Brendan D., Furge, Kyle A., Dykema, Karl J., Koeman, Julie, Swiatek, Pamela J., Giordano, Thomas J., West, Andrew B., Resau, James H., Teh, Bin T., MacKeigan, Jeffrey P.
Publicado em 2011